OC-AUTO® FIT

Screening Resource Center

Reach your CRC screening goals

Offering annual noninvasive screening with OC-Auto FIT to patients 45-75 years of age at average-risk is a guideline-recommended strategy that allows your organization to prioritize colonoscopies for patients with precancerous or cancerous growths, reducing wait times, and preserving valuable resources.

Polymedco’s customizable, programmatic screening solutions help health systems increase patient participation, identify disease earlier, and reduce mortality rates while reducing costs and providing quality care.1,2

Featured Resources

Provider information

Program overview sheet

Promote screening with Polymedco’s collaboration using OC-Auto FIT.

Physician outreach letter

Send to providers to share data and insights about the benefits of OC-Auto FIT.

Physician information sheet

Share quick facts about CRC and recommendations for screening with OC-Auto FIT.

Patient education

Patient brochure

Make brochures available for patients in waiting areas, exam rooms, or the reception area.

Introduction letter template

Reach out to patients directly with information about screening with OC-Auto FIT.

Phone call script

Download a customizable script for calling patients about screening with OC-Auto FIT.

Text message template

Customize the template with a brief text message to patients about OC-Auto FIT.

Health system implementation

Social media post template

Use the customizable template to announce or amplify your OC-Auto FIT screening initiative on social media.

Press release template

Make your community aware of your CRC screening offerings with a customizable press release template.

Contact Polymedco
References
  1. Levin TR, Corley DA, Jensen CD, et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155(5):1383-1391.e5 doi:10.1053/j.gastro.2018.07.017
  2. Allen CJ, Bloom N, Rothka M, et al. Comprehensive cost implications of commercially available noninvasive colorectal cancer screening modalities. J Am Coll Surg. 2023;237(3):465-472. doi:10.1097/XCS.0000000000000768